Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19

Bose RJ, McCarthy JR.

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, Lei F, Chen MM, Yang H, Bai L, Song X, Lin L, Xia M, Zhou F, Zhou J, She ZG, Zhu L, Ma X, Xu Q, Ye P, Chen G, Liu L, Mao W, Yan Y, Xiao B, Lu Z, Peng G, Liu M, Yang J, Yang L, Zhang C, Lu H, Xia X, Wang D, Liao X, Wei X, Zhang BH, Zhang X, Yang J, Zhao GN, Zhang P, Liu PP, Loomba R, Ji YX, Xia J, Wang Y, Cai J, Guo J, Li H.

Relationship Between ACE2 and Other Components of the Renin-Angiotensin System

Cohen JB, Hanff TC, Bress AP, South AM.

COVID-19 and simultaneous thrombosis of two coronary arteries

Rey JR, Jiménez Valero S, Poveda Pinedo D, Merino JL, López-Sendón JL, Caro-Codón J.

[COVID-19 and its relationship with hypertension and cardiovascular disease]

Salazar M, Barochiner J, Espeche W, Ennis I.

The Rapid Transformation of Cardiac Surgery Practice in the Coronavirus Disease 2019 (COVID-19) Pandemic: Insights and Clinical Strategies From a Center at the Epicenter

George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M.

Syncope, Near Syncope, or Nonmechanical Falls as a Presenting Feature of COVID-19

Chen T, Hanna J, Walsh EE, Falsey AR, Laguio-Vila M, Lesho E.

Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19

Mahajan K, Chand Negi P, Ganju N, Asotra S.

A case of Covid-19 patient with acute limb ischemia and heparin resistance

Baccellieri D, Bilman V, Apruzzi L, Monaco F, D'Angelo A, Loschi D, Melissano G, Chiesa R.

Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients

Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, Ortega Pérez R, Rivas S, Martínez-Moya R, Sanromán MA, Manzano L, Alonso GL, Ibáñez B, Zamorano JL.

Prioritizing elective cardiovascular procedures during the COVID-19 pandemic: The cardiovascular medically necessary, time-sensitive procedure scorecard

Waxman S, Garg A, Torre S, Wasty N, Roelke M, Cohen M, Salemi A.

Successful Heart Transplantation to a Fulminant Myocarditis Patient during COVID-19 Outbreak - Lessons Learned

Kim IC, Hwang I, Kim YS, Kim JB.

Updates of Cardiovascular Manifestations in COVID-19: Korean Experience to Broaden Worldwide Perspectives

Kim IC, Kim HA, Park JS, Nam CW.

COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches

Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT.

QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection

Bun SS, Taghji P, Courjon J, Squara F, Scarlatti D, Theodore G, Baudouy D, Sartre B, Labbaoui M, Dellamonica J, Doyen D, Marquette CH, Levraut J, Esnault V, Bun SS, Ferrari E.

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study

Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte Salles T, Fernandez Bertolin S, Aragon M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, AlShammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats Uribe A, Zhang L, Areia C, Krumholz H, Prieto Alhambra D, Ryan PB, Hripcsak G, Suchard MA.

Management of ST-Elevation Myocardial Infarction in the COVID-19 Era: The Role of Thrombosis and Anticoagulation Strategy

Al-Sadawi M, Mohiuddin A, Hossain N, Shaikh S, Feit A, Ramalanjaona B, Salifu MO, McFarlane SI.

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients

Yanai H.

Susceptibility and prognosis of COVID-19 patients with cardiovascular disease

Wang BX.

Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

Si D, Du B, Ni L, Yang B, Sun H, Jiang N, Liu G, Massé S, Jin L, Nanthakumar J, Bhaskaran A, Yang P, Nanthakumar K.

COVID-19 and myocardial injury

Alexander B, Baranchuk A.

Acute coronary syndrome and shock in the context of acute COVID-19 infection

Cárdenes León A, Hernández Meneses B, Sánchez Pérez A, Novoa Medina JM, Bujanda Morún PF, Martín Lorenzo P.

Coronary and structural heart disease interventions during COVID-19 pandemic: A road map for clinicians and health care delivery systems

Harjai KJ, Agarwal S, Bauch T, Bernardi M, Casale AS, Green S, Harostock M, Ierovante N, Mascarenhas V, Matsumura M, Nawaz Y, Scott T, Singh D, Stella JJ, Vijayaraman P, Yost G, Blankenship JC.

The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19

Pezel T, Lima JAC.

Impact of COVID-19 pandemic in cardiology admissions

Negreira Caamaño M, Piqueras Flores J, Mateo Gómez C.

Electrocardiographic features of patients with COVID-19 pneumonia

Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G, Feci D, Reboldi G, Fabbri LM, Verdecchia P.

Management of acute myocardial injury in patients with confirmed or suspected COVID-19

Chatzizisis YS, Gajanan G, Bhatt DL, Dangas G, Porter T.

Saudi Society for Cardiac Surgeons consensus document on COVID-19, April 1, 2020

Albacker TB, Eskandar K, Ismail H, Tash A, Alkhamees K, Alhalees Z, Abu-Khudair W.

The Impact of Isolation Measures Due to COVID-19 on Energy Intake and Physical Activity Levels in Australian University Students

Gallo LA, Gallo TF, Young SL, Moritz KM, Akison LK.

Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 Pandemic

Damiot A, Pinto AJ, Turner JE, Gualano B.

Cardiovascular collateral damages at the time of COVID-19

Jacques F, Voisine P, Perrault L.

COVID-19 and Cardiac Arrhythmias

Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, Moss J, Chahal AA, Anesi G, Denduluri S, Domenico CM, Arkles J, Abella BS, Bullinga JR, Callans DJ, Dixit S, Epstein AE, Frankel DS, Garcia FC, Kumareswaram R, Nazarian S, Riley MP, Santangeli P, Schaller RD, Supple GE, Lin D, Marchlinski F, Deo R.

A call to action becomes practice: cardiac and vascular surgery during the COVID-19 pandemic based on the Lombardy emergency guidelines

Bonalumi G, Giambuzzi I, Barbone A, Ranieri C, Cavallotti L, Trabattoni P, Naliato M, Polvani G, Torracca L, Pelenghi S, Ragni F, Russo CF, Guerra F, Trimarchi S, Civilini E, Romani F, Bellosta R, Losa S, Roberto M, Alamanni F.

Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemic

Greco A, Spagnolo M, Capodanno D.

Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'

Piepoli MF.

COVID-19 in Recent Heart Transplant Recipients: Clinicopathologic Features and Early Outcomes

Lima B, Gibson GT, Vullaganti S, Malhame K, Maybaum S, Hussain ST, Shah S, Majure DT, Wallach F, Jang K, Bijol V, Esposito MJ, Williamson AK, Thomas RM, Bhuiya TA, Fernandez HA, Stevens GR.

Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling

Wehbe Z, Hammoud S, Soudani N, Zaraket H, El-Yazbi A, Eid AH.

Echocardiographic Features of COVID-19 Illness and Association with Cardiac Biomarkers

Churchill TW, Bertrand PB, Bernard S, Namasivayam M, Churchill J, Crousillat D, Davis EF, Hung J, Picard MH.

COVID-19 and Heart: From Clinical Features to Pharmacological Implications

Russo V, Bottino R, Carbone A, Rago A, Papa AA, Golino P, Nigro G.

SARS-CoV-2 and Cardiovascular Complications: from Molecular Mechanisms to Pharmaceutical Management

Wu L, O'Kane AM, Peng H, Bi Y, Motriuk-Smith D, Ren J.

Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections

Miyazawa D.

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial

Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dol

Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?

Rabbani AB, Parikh RV, Rafique AM.

Will the COVID-19 Epidemic Reshape Cardiology?

Alkhouli M, Coylewright M, Holmes DR.

New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people

Holt A, Gislason GH, Schou M, Zareini B, Biering-S√∏rensen T, Phelps M, Kragholm K, Andersson C, Fosb√∏l EL, Hansen ML, Gerds TA, K√∏ber L, Torp-Pedersen C, Lamberts M.

COVID-19 Pandemic: Cardiovascular Complications and Future Implications

Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, Pal I, Patel N, Amgai B, Ghosh RK, Fonarow GC, Lavie CJ, Naidu SS.

Atypical Manifestation of COVID-19-Induced Myocarditis

Rehman M, Gondal A, Rehman NU.

[Understanding and prevention of D-dimer elevation in coronavirus disease 2019 in traditional Chinese medicine]

Wang Q, Wang C, Mei J, He L, Li J, Liu S, Chen F.

[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019]

Xu Y, Qian Y, Gu Q, Tang J.

CONGENITAL CARDIAC INTERVENTIONS DURING THE PEAK PHASE OF COVID-19 PANDEMICS IN THE COUNTRY IN A PANDEMICS HOSPITAL IN ISTANBUL

Ugurlucan M, Yildiz Y, Oztas DM, Coban S, Beyaz MO, Sari G, Ulukan MO, Karakaya A, Vatansever B, Erkanli K, Meric M, Unal O, Demirkol D, Yozgat Y, Saritas T, Erdem A, Akdeniz C, Turkoglu H.

Association between angiotensin blockade and COVID-19 severity in Hong Kong

Cheung KS, Hung IFN, Leung WK.

Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19

Quinn KL, Fralick M, Zipursky JS, Stall NM.

Mendelian randomization in COVID-19: Applications for cardiovascular comorbidities and beyond

Teng Y, Xu J, Zhang Y, Liu Z, Zhang S.

COVID-19 Concomitant Infective Endocarditis: A-Case Report and Review of Management

Amir M, Djaharuddin I, Sudharsono A, Ramadany S.

Renewed KIDS SAVE LIVES campaign to further increase awareness and fight sudden cardiac death in the era of Covid-19

Semeraro F, Ristagno G, Greif R, Lockey A, Monsieurs KG, Nolan JP, Olasveengen TM, Perkins GD, Scapigliati A, Böttiger BW.

The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials

Lumbers ER, Delforce SJ, Pringle KG, Smith GR.

Comparative Analysis of Early-Stage Clinical Features Between COVID-19 and Influenza A H1N1 Virus Pneumonia

Shen C, Tan M, Song X, Zhang G, Liang J, Yu H, Wang C.

Recommendations for Physical Inactivity and Sedentary Behavior During the Coronavirus Disease (COVID-19) Pandemic

Ricci F, Izzicupo P, Moscucci F, Sciomer S, Maffei S, Di Baldassarre A, Mattioli AV, Gallina S.

Heart Transplant Recipient Patient with COVID-19 Treated with Tocilizumab

Mattioli M, Fustini E, Gennarini S.

The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre

George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M.

Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion

Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B, Li J, Wang Z, Wu W, Wu M, Li W, Li L, Cai Y, Bosco B, Zhong A, Liu X, Lv T, Gan Z, Chen G, Pan Y, Liu C, Zhang K, Xu X, Wang C, Wang Q.

Myocardial injury in patients with COVID-19

Lim GB.

"Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease"

Mattioli AV, Sciomer S, Cocchi C, Maffei S, Gallina S.

Cardiopulmonary exercise testing in the COVID-19 endemic phase

Faghy MA, Sylvester KP, Cooper BG, Hull JH.

Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

Khider L, Soudet S, Laneelle D, Boge G, Bura-Rivière A, Constans J, Dadon M, Desmurs-Clavel H, Diard A, Elias A, Emmerich J, Galanaud JP, Giordana P, Gracia S, Hamade A, Jurus C, Le Hello C, Long A, Michon-Pasturel U, Mirault T, Miserey G, Perez-Martin A, Pernod G, Quere I, Sprynger M, Stephan D, Wahl D, Zuily S, Mahe G, Sevestre MA; French Society of Vascular Medicine (SFMV).

Pulmonary arterial hypertension and COVID-19

Avellanas Chavala ML.

COVID-19 pandemia and inherited cardiomyopathies and channelopathies: a short term and long term perspective

Limongelli G, Crotti L.

Cholesterol in Relation to COVID-19: Should We Care about It?

Radenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M.

Microvascular disease confers additional risk to COVID-19 infection

Bale BF, Doneen AL, Vigerust DJ.

Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York

Braiteh N, Rehman WU, Alom M, Skovira V, Breiteh N, Rehman I, Yarkoni A, Kahsou H, Rehman A.

Poor outcome of intestinal ischemic manifestations of COVID 19

Norsa L, Pietro B, Indriolo A, Valle C, Aurelio S, Sironi S.

Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease

Barman HA, Atici A, Sahin I, Alici G, Aktas Tekin E, Baycan ÖF, Ozturk F, Oflar E, Tugrul S, Yavuz MB, Celik FB, Oktay A, Vahaboglu H, Adas M, Turgut N, Okuyan E, Yıldırmak MT, Gungor B.

The compelling arguments for the need for microvascular investigation in COVID-19 critical patients

Martini R.

Home-based exercise note in Covid-19 quarantine situation for office workers: A commentary

Shariat A, Hakakzadeh A, Cleland J.

COVID-19 and vascular surgery at a central London teaching hospital

Rolls A, Sudarsanam A, Luo X, Aylwin C, Bicknell CD, Davies AH, Gibbs RGJ, Jaffer U, Jenkins MP, Nott D, Riga CV, Shalhoub J, Sritharan G, Standfield NJ.

Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies

Parohan M, Yaghoubi S, Seraji A.

Epidemiological Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan

Semenova Y, Glushkova N, Pivina L, Khismetova Z, Zhunussov Y, Sandybaev M, Ivankov A.

Chloroquine cardiac effects and toxicity.A short update

Mubagwa K.

Recommendations for risk stratified use of cardiac computed tomography for congenital heart disease during the COVID-19 pandemic

Farooqi KM, Ghoshhajra BB, Shah AM, Chelliah A, Einstein AJ, Hlavacek A, Han BK.

Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic

Romaguera R, Ribera A, Güell-Viaplana F, Tomás-Querol C, Muñoz-Camacho JF, Agudelo V; Codi IAM investigators.

COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack?

Arnold RH.

COVID-19 pandemic and the impact on the cardiovascular disease patient care

Kulkarni P, Mahadevappa M, Alluri S.

Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2

Ji H, de Souza AMA, Bajaj B, Zheng W, Wu X, Speth RC, Sandberg K.

Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension

Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M; SARS-RAS Investigator.

Heart failure related hospitalisation and management during COVID-19 pandemic: are we ready to reflect? - REPLY

De Filippo O, D'Ascenzo F, De Ferrari GM.

Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths

Surma S, Romańczyk M, Łabuzek K.

Contemporary and Future Concepts on Hypertension in African Americans: COVID-19 and Beyond

Ferdinand K, Batieste T, Fleurestil M.

Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report

Vaidya G, Czer LSC, Kobashigawa J, Kittleson M, Patel J, Chang D, Kransdorf E, Shikhare A, Tran H, Vo A, Ammerman N, Huang E, Zabner R, Jordan S.

Letter to the EditorCARDIAC INJURY AND PROGNOSIS IN COVID-19: METHODOLOGICAL CONSIDERATIONS AND UPDATED META-ANALYSIS

Kollias A, Kyriakoulis KG, Destounis A, Stergiou GS, Syrigos K.

Apelin-potential therapy for COVID-19?

Saravi SSS, Beer JH.

Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab

Wenzel P, Kopp S, Göbel S, Jansen T, Geyer M, Hahn F, Kreitner KF, Escher F, Schultheiss HP, Münzel T.

COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests

Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Oltrona Visconti L, Savastano S; Lombardia CARe researchers.

Multi-modality imaging of inflammation and ischemia for assessment of myocardial injury in Covid-19

Yousefi-Koma A, Naghashzadeh F, Figtree GA, Patel S, Karimi Galougahi K.

COVID-19 and the RAAS

Naik GOA.

Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes

Baggish A, Drezner JA, Kim J, Martinez M, Prutkin JM.

Clinical features of COVID-19 and influenza: A comparative study on Nord Franche-Comte cluster

Zayet S, Kadiane-Oussou NJ, Lepiller Q, Zahra H, Royer PY, Toko L, Gendrin V, Klopfenstein T.

The Impact of the COVID-19 Pandemic on Cardiovascular Fellows-in-Training: A National Survey

Rao P, Diamond J, Korjian S, Martin L, Varghese M, Serfas JD, Lee R, Fraiche A, Kannam J, Reza N; American College of Cardiology Fellows-in-Training Section Leadership Council.

The Impact of COVID-19 on Cardiovascular Training Programs: Challenges, Responsibilities and Opportunities

Weissman G, Arrighi JA, Botkin NF, Damp JB, Keating FK, Menon V, Rose-Jones LJ, Singh HS, Soukoulis V, Kates AM.

Necessity of 45-Day Transesophageal Echocardiography After the WATCHMAN Procedure Amid the COVID-19 Pandemic

Tan BE, Depta JP, Baibhav B, Bhatt DL.

Potential role of telemedicine in solving ST-segment elevation dilemmas in remote areas during the COVID-19 pandemic

Pranata R, Tondas AE, Huang I, Lim MA, Siswanto BB, Meyer M, Mitrovic V.

Mental Health and Psychosocial Challenges in the COVID-19 Pandemic: Food for Thought for Cardiovascular Health Care Professionals

O'Neil A, Nicholls SJ, Redfern J, Brown A, Hare DL.

Transesophageal Echocardiography Remains Essential and Safe during Prone Ventilation for Hemodynamic Monitoring of Patients with COVID-19

Evrard B, Goudelin M, Vignon P.

Tricuspid Longitudinal Annular Displacement for the Assessment of Right Ventricular Systolic Dysfunction during Prone Positioning in Patients with COVID-19

Beyls C, Bohbot Y, Huette P, Abou-Arab O, Mahjoub Y.

COVID-19 myocardial injury: We have much more to discover

Vrachatis DA, Giotaki SG, Giannopoulos G.

Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence

Hu B, Deng Q, Zhou Q.

Heroism in the Face of the COVID-19 Pandemic

Kirtane AJ, Mehran R, Navar AM, Bonow RO.

Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19

Curfman G.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

Fosbøl EL, Butt JH, Østergaard L, Andersson C, Selmer C, Kragholm K, Schou M, Phelps M, Gislason GH, Gerds TA, Torp-Pedersen C, Køber L.

Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City

Lai PH, Lancet EA, Weiden MD, Webber MP, Zeig-Owens R, Hall CB, Prezant DJ.

COVID-19 cardiac involvement in a 38-day old infant

Del Barba P, Canarutto D, Sala E, Frontino G, Guarneri MP, Camesasca C, Baldoli C, Esposito A, Barera G.

Impact of COVID-19 on cardiac surgical training: Our experience in the United Kingdom

Shafi AMA, Atieh AE, Harky A, Sheikh AM, Awad WI.

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.

B lines in COVID-19: "Unspecificity" is not "meaningless"

Vetrugno L, Bove T, Orso D, Barbariol F, Bassi F, Boero E, Ferrari G, Kong R.

A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs

Yu WL, Toh HS, Liao CT, Chang WT.

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability

Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R.

Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?

Fraser AG, Szymański P, Macintyre E, Landray M.

EHRA 2020 during COVID-19 days

Burri H, Zeppenfeld K, Heidbuchel H.

Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank

Raisi-Estabragh Z, McCracken C, Bethell MS, Cooper J, Cooper C, Caulfield MJ, Munroe PB, Harvey NC, Petersen SE.

Global evaluation of echocardiography in patients with COVID-19

Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, White A, Salvo GD, Sade LE, Pearce K, Newby DE, Popescu BA, Donal E, Cosyns B, Edvardsen T, Mills NL, Haugaa K.

CMR and serology to diagnose COVID-19 infection with primary cardiac involvement

Gravinay P, Issa N, Girard D, Camou F, Cochet H.

[Cardiac rehabilitation and secondary prevention programs during the COVID-19 pandemic: what's "COVID on"?]

Mureddu GF, Giallauria F, Venturini E, Fattirolli F, Ambrosetti M.

[Role of the cardiac surgeon in the COVID-19 hospital]

Ramoni E, Magnano D, Del Giglio M.

[Return to sport after the COVID-19 pandemic. How to behave?]

Lodi E, Scavone A, Carollo A, Guicciardi C, Reggianini L, Savino G, Modena MG.

[ANMCO Position paper: Role of cardiology in the management of health needs in the post-COVID-19 era]

Murrone A, Colivicchi F, Roncon L, Caldarola P, Amodeo V, Urbinati S, Di Lenarda A, Valente S, Aspromonte N, Cipriani M, Domenicucci S, Francese GM, Imazio M, Scotto di Uccio F, Scherillo M, Di Pasquale G, Gulizia MM, Gabrielli D.

[Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience]

Vecchio S, Fileti L, Reggi A, Moschini C, Lorenzetti S, Rubboli A.

[Coagulopathy in COVID-19: pathophysiology]

Pierini S, Incampo E, Bokor D, Dadone V, Ornaghi M, Zanini F, Gentile F, Mancarella S.

[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]

Di Pasquale G, Maggioni AP.

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

Itoh H.

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug

Benítez-Cardoza CG, Vique-Sánchez JL.

Characteristics, Cardiac involvement, and Outcomes of Multisystem Inflammatory Disease of Childhood (MIS-C) Associated with SARS-CoV-2 Infection

Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L, Schleien C; Northwell Health COVID-19 Research Consortium, Epstein S, Johnson JC, Kessel A, Misra N, Mitchell E, Palumbo N, Rajan S, Rocker J, Williamson K, Davidson KW.

Cardiac Rehabilitation during the COVID-19 Era: Guidance on Implementing Virtual Care

Moulson N, Bewick D, Selway T, Harris J, Suskin N, Oh P, Coutinho T, Singh G, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lamarche Y, Lau B, Légaré JF, Leong-Poi H, Mansour S, Marelli A, Quraishi AUR, Roifman I, Ruel M, Sapp J, Small G, Turgeon R, Wood DA, Zieroth S, Virani S, Krahn AD.

Drugs acting on renin angiotensin system and use in ill patients with COVID-19

Alexandre J, Cracowski JL, Richard V, Bouhanick B; French Society of Pharmacology and Therapeutics (SFPT).

Cardio-onco-hematology patients' management in the context of the current COVID-19 pandemic

Lorca R, López Triviño R, Morís C.

Spontaneous Coronary Artery Dissection in a Patient With COVID-19

Courand PY, Harbaoui B, Bonnet M, Lantelme P.

Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients

Beigmohammadi MT, Jahanbin B, Safaei M, Amoozadeh L, Khoshavi M, Mehrtash V, Jafarzadeh B, Abdollahi A.

Perspectives on Cardiopulmonary Critical Care for COVID-19 Patients: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Maron BA, Gladwin MT, Bonnet S, De Jesus Perez V, Perman SM, Yu PB, Ichinose F.

COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension

Pinto VM, Derchi GE, Bacigalupo L, Pontali E, Forni GL.

COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead

Gentile F, Aimo A, Forfori F, Catapano G, Clemente A, Cademartiri F, Emdin M, Giannoni A.

NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19

Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC, Boucherat O, Bonnet S, Provencher S.

Perioperative planning in the COVID-19 pandemic: Cardiovascular perfusion and device-related issues

Günaydın S.

Perioperative planning in the COVID-19 pandemic: Vascular issues

Akay T.

Perioperative planning for cardiovascular operations in the COVID-19 pandemic

Mavioğlu HL, Ünal EU, Aşkın G, Küçüker ŞA, Özatik MA.

Turkish Society of Cardiovascular Surgery (TSCVS) Proposal for use of ECMO in respiratory and circulatory failure in COVID-19 pandemic era

Akar AR, Ertugay S, Kervan Ü, İnan MB, Sargın M, Engin Ç, Özatik MA.

Pulmonary embolism and COVID-19. Persistent pulmonary hypertension?

Cruz-Utrilla A, Calderón-Flores M, Escribano-Subias MP.

Coronavirus disease 2019 and cardiovascular system: A narrative review

Kwenandar F, Japar KV, Damay V, Hariyanto TI, Tanaka M, Lugito NPH, Kurniawan A.

As the COVID-19 pandemic drags on, where have all the STEMIs gone?

Ullah W, Sattar Y, Saeed R, Ahmad A, Boigon MI, Haas DC, Alraies MC.

Bradycardia in Patients With COVID-19: A Calm Before the Storm?

Amaratunga EA, Corwin DS, Moran L, Snyder R.

Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?

Vikse J, Lippi G, Henry BM.

Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?

Aamodt AH, Bj√∏rk MH, Tronvik EA, Buanes EA, Stovner LJ, Atar D.

Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation)

Mureddu GF, Ambrosetti M, Venturini E, La Rovere MT, Mazza A, Pedretti R, Sarullo F, Fattirolli F, Faggiano P, Giallauria F, Vigorito C, Angelino E, Brazzo S, Ruzzolini M.

Clinical characteristics, diagnosis, and treatment of COVID-19: A case report

He YF, Lian SJ, Dong YC.

Management of hypertension in COVID-19

Antwi-Amoabeng D, Beutler BD, Moody AE, Kanji Z, Gullapalli N, Rowan CJ.

Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19

Han YL, Li YM, Ma CS.

The Covid-19 pandemic and India's cardiovascular disease burden: Finding the right balance

Chalasani M, Nasir K, Gupta MD, Kalra A.

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection

Pons S, Fodil S, Azoulay E, Zafrani L.

The American Heart Association COVID-19 CVD Registry powered by Get With The Guidelines®

Alger HM, Rutan C, Williams Iv JH, Walchok JG, Bolles M, Hall JL, Bradley SM, Elkind MSV, Rodriguez F, Wang TY, Morrow DA, Das SR, de Lemos JA.

Electrocardiographic Findings in COVID-19: Insights on Mortality and Underlying Myocardial Processes

McCullough SA, Goyal P, Krishnan U, Choi JJ, Safford MM, Okin PM.

Low prevalence of arrhythmias in clinically stable COVID-19 patients

Sala S, Peretto G, De Luca G, Farina N, Campochiaro C, Tresoldi M, Dagna L, Zangrillo A, Gulletta S, Bella PD.

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I.

COVID-19: The heart of the issue

Woodward B, Kermali M.

Cardiovascular disease and the impact of COVID-19

Yoganathan A, Sajjad MS, Harky A.

Kawasaki Disease Features and Myocarditis in a Patient with COVID-19

Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M.

Myocardial work index: a glimmer of hope in COVID-19

Jaglan A, Roemer S, Jan MF, Khandheria BK.

A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers

Grover A, Oberoi M.

COVID-19 pandemic in India

Ram VS, Babu GR, Prabhakaran D.

Coronavirus Disease and New-Onset Atrial Fibrillation: Two Cases

Taha ME, Alsafi W, Taha M, Eljack A, Ibrahim H.

[Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes]

Yang H, Yang LC, Zhang RT, Ling YP, Ge QG.

COVID-19 Preoperative Assessment and Testing: From Surge to Recovery

Lu AC, Schmiesing CA, Mahoney M, Cianfichi L, Semple AK, Watt D, Fischer S, Wald SH.

[ECG pearl: prone position ECG for COVID-19 patients]

Tomcs√°nyi J.

Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient

Taza F, Zulty M, Kanwal A, Grove D.

Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, Harding CV, Hurwitz JL, Jeffery CC, Krahn AD, Kusumoto FM, Lampert R, Mansour M, Natale A, Patton KK, Seiler A, Shah MJ, Wang PJ, Russo AM.

Role of Helmet-Delivered Noninvasive Pressure Support Ventilation in COVID-19 Patients

Ing RJ, Bills C, Merritt G, Ragusa R, Bremner RM, Bellia F.

Sport and exercise during and beyond the COVID-19 pandemic

Yeo TJ.

Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2

Kielty J, Duggan WP, O'Dwyer M.

Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection

Rath D, Petersen-Uribe Á, Avdiu A, Witzel K, Jaeger P, Zdanyte M, Heinzmann D, Tavlaki E, Müller K, Gawaz MP.

SARS-COV-2 Presenting as New Onset Atrial Fibrillation: A Case Report

Harhay J, Khan M, Shah S, Malhotra A.

Mechanisms of Myocardial Injury in Coronavirus Disease 2019

Rali AS, Ranka S, Shah Z, Sauer AJ.

Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?

Low TT, Cherian R, Lim SL, Chandra B, Tung ML, Kumar SK, Lye P, Chin Xin Yi A, Teo L, Tay EL.

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

Komiyama M, Hasegawa K, Matsumori A.

[Cardiac surgery in COVID-19 times: need for specialist information]

Kallenbach K.

Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19)

Xie Y, You Q, Wu C, Cao S, Qu G, Yan X, Han X, Wang C, Zhang H.

COVID-19 in a young man with hypertension: A case study of missed opportunities in intensive progression

Rao K, Xie L, Wu J, Weng T, Tang L, Zhou J.

Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection

Judson GL, Kelemen BW, Njoroge JN, Mahadevan VS.

Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?

Drager LF, Pio-Abreu A, Lopes RD, Bortolotto LA.

COVID-19 and Katrina: recalcitrant racial disparities

Van Spall HGC, Yancy CW, Ferdinand KC.

Behavior of the PR Interval with Increasing Heart Rate in Patients with COVID-19

Pavri BB, Kloo J, Farzad D, Riley JM.

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic

Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, Chung MK, Conte G, Dagher L, Epstein LM, Ghanbari H, Han JK, Heidbuchel H, Huang H, Lakkireddy DR, Ngarmukos T, Russo AM, Saad EB, Saenz Morales LC, Sandau KE, Sridhar ARM, Stecker EC, Varosy PD.

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic

Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, Chung MK, Conte G, Dagher L, Epstein LM, Ghanbari H, Han JK, Heidbuchel H, Huang H, Lakkireddy DR, Ngarmukos T, Russo AM, Saad EB, Saenz Morales LC, Sandau KE, Sridhar ARM, Stecker EC, Varosy PD.

Spontaneous coronavirus disease 2019 (COVID-19)-associated luminal aortic thrombus

Mullan C, Powierza C, Miller PE, Geirsson A, Vallabhajosyula P, Assi R.

Cardiological Society of India: Document on acute MI care during COVID-19

Kerkar PG, Naik N, Alexander T, Bahl VK, Chakraborty RN, Chatterjee SS, Chopra HK, Dani SI, Deb PK, Goswami KC, Guha S, Gupta R, Gupta V, Hasija PK, Jayagopal PB, Justin Paul G, Kahali D, Katyal VK, Khanna NN, Mandal M, Mishra SS, Mohanan PP, Mullasari A, Mehta S, Pancholia AK, Ray S, Roy D, Shanmugasundarm S, Sharma S, Singh BP, Tewari S, Tyagi SK, Venugopal KN, Wander GS, Yadav R, Das MK.

Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given

Malviya A.

Involvement of Cardiovascular System As The Critical Point in Coronavirus Disease 2019 (COVID-19) Prognosis and Recovery

Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, Vassilikos V, Stellos K.

Further aspects of doxycycline therapy in COVID-19

Szolnoky G.

COVID-19 and the heart: An update for clinicians

Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E.

Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria

Kiblboeck D, Kellermair J, Siostrzonek P, Steinwender C.

Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic

Enache B, Claessens YE, Boulay F, Dor V, Eker A, Civaia F, Pathak A.

COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response

Ryan PM, Caplice N.

COVID-19 mimicking dengue fever with the initial manifestation of retro-orbital pain - A Rare Case

Ruiy W, Hsu SY, Tsai HL, Chen CT.

Exercising in Times of Lockdown: An Analysis of the Impact of COVID-19 on Levels and Patterns of Exercise among Adults in Belgium

Constandt B, Thibaut E, De Bosscher V, Scheerder J, Ricour M, Willem A.

Are individuals with cardiovascular disease at risk of COVID-19-related mental health problems or individuals with cardiovascular disease at risk of cardiovascular disease-related mental health problems during COVID-19? A psychological-psychiatric perspective

Mukhtar S.

Intra-abdominal hypertension as a trigger of "gut failure" in SARS-CoV-2 infection: Effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function

Di Grezia M, Fransvea P, Santullo F, Tirelli F, Fico V, Mirco P, Cozza V, La Greca A, Sganga G.

Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19

Tibirica E, De Lorenzo A.

Transforming ambulatory heart failure care in the COVID-19 era: initial experience from a heart failure disease management clinic

Umapathi P, Cuomo K, Riley S, Hubbard A, Menzel K, Sauer E, Gilotra NA.

Bedside veno-venous ECMO cannulation: A pertinent strategy during the COVID-19 pandemic

Calcaterra D, Heather B, Kohl LP, Erickson HL, Prekker ME.

Cardiac surgery in patients with confirmed COVID-19 infection: Early experience

Hussain A, Khan H, Lopez-Marco A, Roberts N, Oo A.

COVID-19 pandemic: Beyond medical education in Brazil

Carvalho VO, Conceição LSR, Gois MB Jr.

Comment on "ACE inhibitors and COVID-19: We don't know yet"

Ilcol TB, Cure E, Cumhur Cure M.

Response to COVID-19 pandemic: Beyond medical education in Brazil

Newman NA, Lattouf OM.

ACEi and ARB with COVID-19

Khashkhusha TR, Chan JSK, Harky A.

Association between renin-angiotensin system inhibitors and COVID-19 complications

Liabeuf S, Moragny J, Bennis Y, Batteux B, Brochot E, Schmit JL, Lanoix JP, Andrejak C, Ganry O, Slama M, Maizel J, Mahjoub Y, Masmoudi K, Gras-Champel V.

Fulminant COVID-19-related myocarditis in an infant

Kesici S, Aykan HH, Orhan D, Bayrakci B.

EP lessons by Legendary Quartet of "Jackman-Klein-Prystowsky-Stevenson": "A Priceless Opportunity" during the COVID-19 Era

Ozeke O, Cay S, Ozcan F, Korkmaz A, Kara M, Topaloglu S, Aras D.

Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis

Toraih EA, Elshazli RM, Hussein MH, Elgaml A, Amin MN, El-Mowafy M, El-Mesery M, Ellythy A, Duchesne J, Killackey MT, Ferdinand KC, Kandil E, Fawzy MS.

Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology

Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, Harding CV, Hurwitz JL, Jeffery CC, Krahn AD, Kusumoto FM, Lampert R, Mansour M, Natale A, Patton KK, Seiler A, Shah MJ, Wang PJ, Russo AM.

Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies

Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A, Wenzel P, Hamm C, Westenfeld R, Schultheiss M, Gross U, Morawietz L, Schultheiss HP.

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, Kouides P.

Statin therapy in COVID-19 infection: much more than a single pathway

Bifulco M, Gazzerro P.

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study

Bidulka P, Iwagami M, Mansfield KE, Kalogirou F, Wong AYS, Douglas IJ, Smeeth L, Summers C, Tomlinson LA.

A Review of Cardiac Complications in Coronavirus Disease 2019

Singh R, Kashyap R, Hutton A, Sharma M, Surani S.

Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review

Tahir F, Bin Arif T, Ahmed J, Malik F, Khalid M.

[The RAAS and SARS-CoV-2: A riddle to solve]

Choi M, Aiello EA, Ennis IL, Villa-Abrille MC.

Endovascular simulation as a supplemental training tool during the COVID-19 national emergency

Kesselman A, Lamparello NA, Malhotra A, Winokur RS, Pua BB.

Cardiac injuries in coronavirus disease 2019 (COVID-19)

Chen C, Li H, Hang W, Wang DW.

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

Pinto BGG, Oliveira AER, Singh Y, Jimenez L, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HI.

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic

Varma N, Marrouche NF, Aguinaga L, Albert CM, Arbelo E, Choi JI, Chung MK, Conte G, Dagher L, Epstein LM, Ghanbari H, Han JK, Heidbuchel H, Huang H, Lakkireddy DR, Ngarmukos T, Russo AM, Saad EB, Saenz Morales LC, Sandau KE, Sridhar ARM, Stecker EC, Varosy PD.

Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications

Hrenak J, Zorad S, Simko F.

Multi-System Inflammatory Syndrome in Children in Association with COVID-19

Simpson JM, Newburger JW.

Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China

Chen D, Li X, Song Q, Hu C, Su F, Dai J, Ye Y, Huang J, Zhang X.

Physical activity during the COVID-19 global pandemic

Ainsworth BE, Li F.

Management and outcomes of a Vascular Surgery Department with sudden medical staff outbreak of COVID-19

Pereira-Neves A, Rocha-Neves J, Cerqueira A, Fernando-Teixeira J.

European Resuscitation Council COVID-19 Guidelines Executive Summary

Nolan JP, Monsieurs KG, L Bossaert, Böttiger BW, Greif R, Lott C, Madar J, Olasveengen TM, Roehr CC, Semeraro F, Soar J, Van de Voorde P, Zideman DA, Perkins GD.

Thrombotic microangiopathy in a patient with COVID-19

Jhaveri KD, Meir LR, Flores Chang BS, Parikh R, Wanchoo R, Barilla-LaBarca ML, Bijol V, Hajizadeh N.

Cardiometabolic Risk Factor Control During Times of Crises and Beyond

Brook RD, Levy P, Rajagopalan S.

Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Elevation Myocardial Infarction, Stroke, and Aortic Emergencies

Khot UN, Reimer AP, Brown A, Hustey FM, Hussain MS, Kapadia SR, Svensson LG.

Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic

Giordano A, Biondi-Zoccai G, Frati G, Bartorelli AL.

Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution

Van Camp G, De Beenhouwer H, Beles M, Collet C, Nasser R, Schelfaut D, Penicka M.

D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

Becher Y, Goldman L, Schacham N, Gringauz I, Justo D.

COVID-19 Presenting as Acute Limb Ischaemia

Kaur P, Posimreddy S, Singh B, Qaqa F, Habib HA, Maroules M, Shamoon F.

Stress Cardiomyopathy in COVID-19 Disease

Pasqualetto MC, Secco E, Nizzetto M, Scevola M, Altafini L, Cester A, Rigo F.

Pericardial Fluid in a COVID-19 Patient: Is It Exudate or Transudate?

Allam HH, Kinsara AJ, Tuaima T, Alfakih S.

Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge

Asif T, Kassab K, Iskander F, Alyousef T.

Understanding the current status of patients with pulmonary hypertension during COVID-19 outbreak: a small-scale national survey from China

Zhou H, Zhang G, Deng X, Jin B, Qiu Q, Yan M, Wang X, Zheng X.

COVID-19 and new-onset arrhythmia

Singh S, Desai R.

Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2

Alcocer-Gamba MA, Gutiérrez-Fajardo P, Sosa-Caballero A, Cabrera-Rayo A, Faradji-Hazan RN, Padilla-Padilla FG, Garnica-Cuellar JC, Hernández-Arispe LM, Reyes-Cianeros FA, León-Suárez A, de-Jesús-Rivera J, Mancillas-Adame L, Gaxiola-Macias M, Márquez-Rodríguez E, Miranda-Malpica E, Sanchez-Pedraza V, Lara-Martínez DS, Segovia-Palomo A, Nava-Hernández A, Rivera-Reyes R.

Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2

Medeiros-Domingo A, Carrasco OF, Berni-Betancourt A.

Practice of Cardiology during COVID 19 pandemic. Recommendations of the Mexican Cardiology Community

Sierra-Fernández CR, Alcocer-Gamba MA, Buendía-Hernández A.

Cardiac imaging studies in the COVID-19 pandemic

Pérez-Soriano P, Herrera-Gomar M, Lozoya-Del Rosal JJ, Fajardo-Juárez AI, Olmos-Temois SG, Carbajal-Juárez I.

COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship

Alcocer-Díaz-Barreiro L, Cossio-Aranda J, Verdejo-Paris J, Odin-de-Los-Ríos M, Galván-Oseguera H, Álvarez-López H, Alcocer-Gamba MA.

Protocol for the prevention of ventricular arrhythmias due to treatment in COVID-19 patients

Cueva-Parra Á, Neach-de-la-Vega D, Ortiz-Solis W, Fernández-Domenech J, Lara-Aguilera S, Chi-Pool S, Muñoz-Benavides G, Bustillos-García G, Márquez-Murillo M, Gómez-Flores J, Levinstein-Jacinto M, Mendoza-G C, Nava-Townsend S.

Telemedicine as an instrument for cardiological consultation during the COVID-19 pandemic

Roldán-Gómez FJ, Jordán-Ríos A, Alvarez-Sangabriel A, Guízar-Sánchez C, Pérez-de-Isla L, Lasses-Ojeda LA, Domínguez-Rivera DU, Correa-Carrera RP, Cossío-Aranda JE.

Recommendations for the care of patients with heart failure and COVID-19

Cigarroa-López JA, Magaña-Serrano JA, Álvarez-Sangabriel A, Ruíz-Ruíz V, Chávez-Mendoza A, Méndez-Ortíz A, León-González S, Guízar-Sánchez C, Gutiérrez-Fajardo P, Alcocer-Gamba MA.

Excerpts from the documents of Mexican positions and recommendations in cardiovascular diseases and COVID-19

Alcocer-Gamba MA, Gutiérrez-Fajardo P, Cabrera-Rayo A, Sosa-Caballero A, Piña-Reyna Y, Merino-Rajme JA, Heredia-Delgado JA, Cruz-Alvarado JE, Galindo-Uribe J, Rogel-Martínez U, González-Hermosillo JA, Ávila-Vanzzini N, Sánchez-Carranza JA, Jímenez-Orozco JH, Sahagún-Sánchez G, Fanghänel-Salmón G, Albores-Figueroa R, Carrillo-Esper R, Reyes-Terán G, Cossio-Aranda JE, Borrayo-Sánchez G, de Los Ríos MO, Berni-Betancourt AC, Cortés-Lawrenz J, Leiva-Pons JL, Ortiz-Fernández PH, López

Impact of COVID-19 on reperfusion strategies for acute coronary syndromes

Torres-Escobar G, Gonz√°lez-Pacheco H, Cruz JLB, Arias-Mendoza A, Araiza-Garaygordobil D.

Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak

Piña-Reyna Y, García-Rincón A, Ortiz-Fernández P PH, Alcocer-Gamba MA, Gutiérrez-Fajardo P, Merino-Rajme JA, Reyes-Terán G.

Patient care protocols in cardiac catheterization rooms during the COVID-19 outbreak

Eid-Lidt G, Cortes-Lawrenz J, López-Cuellar J, Leiva-Pons JL, Alcocer-Gamba MA, Farjat-Pasos JI, García-Alcántara JA.

COVID-19 pandemic and the reduction in ST-elevation myocardial infarction admissions

Kulkarni P, Mahadevappa M.

Adult congenital heart disease and the COVID-19 pandemic

Radke RM, Frenzel T, Baumgartner H, Diller GP.

Transcatheter management of severe aortic stenosis during the COVID-19 pandemic

Khialani B, MacCarthy P.

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement

Amirfakhryan H, Safari F.

First documentation of persistent SARS-CoV-2 infection presenting with late acute severe myocarditis

Pavon AG, Meier D, Samim D, Rotzinger DC, Fournier S, Marquis P, Monney P, Muller O, Schwitter J.

First reported case of unrepaired tetralogy of Fallot complicated with Coronavirus Disease-19 (COVID-19)

Moazenzadeh M, Jafari F, Farrokhnia M, Aliramezany M.

COVID-19 in adult patients with congenital heart disease A matter of anatomy or comorbidities?

Ferrero P, Piazza I, Ciuffreda M.

COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey

Sabatino J, Ferrero P, Chessa M, Bianco F, Ciliberti P, Secinaro A, Oreto L, Avesani M, Bucciarelli V, Calcaterra G, Calabrò MP, Russo MG, Bassareo PP, Guccione P, Indolfi C, Di Salvo G.

Leveraging user experience to improve video consultations in a cardiology practice: initial insights during COVID-19

Vandekerckhove P, Vandekerckhove Y, Tavernier R, De Jaegher K, de Mul M.

Heart failure related hospitalisation and management during COVID-19 pandemic: are we ready to reflect?

Nazir T.

Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation

Decker A, Welzel M, Laubner K, Grundmann S, Kochs G, Panning M, Thimme R, Bode C, Wagner D, Lother A.

Fulminant myocarditis and COVID-19

Joob B, Wiwanitkit V.

Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection

Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V; Mount Sinai Covid Informatics Center.

Takotsubo Cardiomyopathy in Males with Covid-19

Giustino G, Croft LB, Oates CP, Rahman K, Lerakis S, Reddy VY, Goldman M.

Severe COVID-19 with debut as bilateral pneumonia, ischemic stroke, and acute myocardial infarction

García Espinosa J, Moya Sánchez E, Martínez Martínez A.

Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?

Tralhão A, Moita LF, Póvoa P.

C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19

Dai X.

Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China

Zhang B, Zhang J, Qian B, Han W, Liu Y, Liu W.

Promoting Physical Activity During the COVID-19 Pandemic: Implications for Obesity and Chronic Disease Management

Hudson GM, Sprow K.

Icarus and Sports After COVID 19: Too Close to the Sun?

Baggish AL, Levine BD.

Why, when, and how to use lung ultrasound during the COVID-19 pandemic: enthusiasm and caution

Gargani L, Soliman-Aboumarie H, Volpicelli G, Corradi F, Pastore MC, Cameli M.

[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic]

Belenkov YN, Snezhitskiy VA, Ardashev AV, Abzaliyeva SA, Cappato R, Karpenko JI, Konev AV, Nechepurenko AA, Raviele A, Puodziukynas A, Sayganov SA, Santini L, Shugaev PL, Yakovleva MV, Zateyshchikov DA, Yuzvinkevitch SA, Zhelyakov EG.

Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series

Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, Levy Y, Sileo C, Schnuriger A, Lorrot M, Guedj R, Ducou le Pointe H.

Cardiovigilance in COVID 19

Kishor K, Marwah R, Anantharaj A, Kalra S.

Clinical tools for cardiorespiratory assessment and rehabilitation: A primary care perspective

Kalra A.

[Forh√∏jet D-dimer og karakteristiske billeddiagnostiske fund hos patient med COVID-19]

Lynggaard SE, Nygaard L, Overgaard EK.

Coronavirus Disease 2019 (COVID-19) Catheterization Laboratory Survey

Banerjee S, Tarantini G, Abu-Fadel M, Banerjee A, Little BB, Sorajja P, Shishehbor MH, Brilakis ES.

Guidance on Acute Management of Atrial Fibrillation in COVID-19

Rattanawong P, Shen W, El Masry H, Sorajja D, Srivathsan K, Valverde A, Scott LR.

Palliative care: Essential support for patients with heart failure in the COVID-19 pandemic

Hill L, Beattie JM, Geller TP, Baruah R, Boyne J, Stolfo GD, Jaarsma T.

Renin-angiotensin system inhibition in COVID-19 patients

de Vries AAF.

Oncocardiology: new challenges, new opportunities

Michel L, Schadendorf D, Rassaf T.

COVID-US: A simplified approach to cardiopulmonary ultrasound in suspected and confirmed COVID-19 patients in surge crisis

Yang Y, Anstey J, Yastrebov K, Nanjayya VB, Orde S, Nalos M, Costello C, Ryan NPG.

Telecardiology in times of the COVID-19 pandemic

Postigo A, González-Mansilla A, Bermejo J, Elízaga J, Fernández-Avilés F, Martínez-Sellés M.

The Importance of Physical Activity to Care for Frail Older Adults During the COVID-19 Pandemic

Aubertin-Leheudre M, Rolland Y.

Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli

Mahan K, Kabrhel C, Goldsmith AJ.

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Liaudet L, Szabo C.

An effective protocol for heart transplantation during COVID-19 outbreak

Boffini M, Pidello S, Simonato E, Barbero C, Attisani M, Trompeo A, De Ferrari GM, Rinaldi M.

Acute myocardial injury in patients hospitalized with COVID-19 infection: A review

Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL.

Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge: a prospective cohort study

You J, Zhang L, Ni-Jia-Ti MY, Zhang J, Hu F, Chen L, Dong Y, Yang K, Zhang B, Zhang S.

COVID-19: from epidemiology to treatment

Pericàs JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, Falces C, Marcos MA, Tuset M, Vilella A, Moreno A, Miro JM; Hospital Clínic Cardiovascular Infections Study Group.

Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives

Felice C, Nardin C, Di Tanna GL, Grossi U, Bernardi E, Scaldaferri L, Romagnoli M, Tonon L, Cavasin P, Novello S, Scarpa R, Farnia A, De Menis E, Rigoli R, Cinetto F, Pauletto P, Agostini C, Rattazzi M.

Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis

Tucker NR, Chaffin M, Bedi KC, Papangeli I, Akkad AD, Arduini A, Hayat S, Eraslan G, Muus C, Bhattacharyya R, Stegmann CM, Margulies KB, Ellinor PT.

Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection

Lala A, Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Januzzi J, Mancini DM, Fuster V.

A Rapid Decrease in Stroke, Acute Coronary Syndrome, and Corresponding Interventions at 65 United States Hospitals Following Emergence of COVID-19

de Havenon A, Ney J, Callaghan B, Delic A, Hohmann S, Shippey E, Yaghi S, Anadani M, Esper G, Majersik J.

Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions

Varshneya M, Irurzun-Arana I, Campana C, Dariolli R, Gutierrez A, Pullinger TK, Sobie EA.

Lifestyle Risk Factors for Cardiovascular Disease in Relation to COVID-19 Hospitalization: A Community-Based Cohort Study of 387,109 Adults in UK

Hamer M, Kivimäki M, Gale CR, Batty GD.

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19

Khera R, Clark C, Lu Y, Guo Y, Ren S, Truax B, Spatz ES, Murugiah K, Lin Z, Omer SB, Vojta D, Krumholz HM.

Telemedicine Outpatient Cardiovascular Care during the COVID-19 Pandemic: Bridging or Opening the Digital Divide?

Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, Adusumalli S.

Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?

de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fern√°ndez-Guarino M.

Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury

Guo J, Wei X, Li Q, Li L, Yang Z, Shi Y, Qin Y, Zhang X, Wang X, Zhi X, Meng D.

Valve-in-valve transcatheter aortic valve replacement in a young patient with a suspected COVID-19 infection: a surgical dilemma in the era of the COVID-19 pandemic

Bauernschmitt R, Gabriel P, Gottardi R, Sodian R.

COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics

Saban-Ruiz J, Ly-Pen D.

Right-Sided Infective Endocarditis

Ashraf H, Decossard P.

Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19

Sinkey RG, Rajapreyar I, Robbins LS, Dionne-Odom J, Pogwizd SM, Casey BM, Tita ATN.

Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19

Violi F, Ceccarelli G, Cangemi R, Alessandri F, d'Ettorre G, Oliva A, Pastori D, Loffredo L, Pignatelli P, Ruberto F, Venditti M, Pugliese F, Mastroianni CM.

COVID-19: Crisis management in congenital heart surgery

Stephens EH, Dearani JA, Guleserian KJ, Overman DM, Tweddell JS, Backer CL, Romano JC, Bacha E.

Rapid outdoor non-compression intubation (RONCI) of cardiac arrests to mitigate COVID-19 exposure to emergency department staff

Kinney B, Slama R.

Acute myocarditis associated with COVID-19 infection

Beşler MS, Arslan H.

One-Lung Ventilation: A Simple Technique to Reduce Air Contamination During the Coronavirus Disease 2019 (COVID-19) Pandemic

Kostroglou A, Alevizou A, Sidiropoulou T.

A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever

Gargiulo L, Pavia G, Facheris P, Valenti M, Sacrini F, Narcisi A, Borroni R, Costanzo A, Mancini LL.

Pregnancy hypertension diagnosis and care in COVID-19 era and beyond

Magee LA, Khalil A, von Dadelszen P.

D-dimer triage for COVID-19

Li C, Hu B, Zhang Z, Qin W, Zhu Z, Zhai Z, Davidson BL, Wang C.

Acute intestinal ischemia in a patient with COVID-19

Bianco F, Ranieri AJ, Paterniti G, Pata F, Gallo G.

The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital

Tsioufis K, Chrysohoou C, Kariori M, Leontsinis I, Dalakouras I, Papanikolaou A, Charalambus G, Sambatakou H, Siassos G, Panagiotakos D, Tousoulis D.

National Clinical Guidance for the Management of Cardiovascular Intervention in the COVID-19 Pandemic: From Bangladesh Society of Cardiovascular Interventions (BSCI)

Uddin MJ, Rahman AF, Rahman S, Momenuzzaman NM, Rahman A, Majumder AS, Mohibullah AM, Chowdhury AH, Malik FN, Ahsan SA, Mohsin K, Haq MM, Chowdhury AW, Sohrabuzzaman AM, Rahman M, Chakraborty B, Rahman R, Khan SR, Khan KN, Reza AM, Hussain KS, Rashid M, Choudhury AK, Karmakar KK, Ali Z, Alam N, Rahman Z, Kabir CS, Banik D, Dutta A, Badiuzzaman M, Islam AW, Sium AH, Hossain MD, Ahmed N, Jahan J, Islam MS, Arefin MM, Cader FA, Banerjee SK, Hoque H, Shofiuddin M, Selim A, Das PK, Ahmed M, Dutto B,

Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?

Huang Y, Xie C, Chen X, Hong Q, Huang H.

Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring

Almufleh A, Ahluwalia M, Givertz MM, Weintraub J, Young M, Cooper I, Shea E, Mehra MR, Desai AS.

Changes in Care Delivery for Patients with Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey

McIlvennan CK, Allen LA, DeVore AD, Kaltenbach LA, Granger CB, Granger BB.

"Strategic cardiac catheterization lab staffing in the era of COVID-19"

Green KM, Lutchmedial SR.

Guiding Cardiac Care during the COVID-19 Pandemic: How Ethics Shapes Our Health System Response

Virani A, Singh G, Bewick D, Légaré JF, Chow CM, Leong-Poi H, Clarke B, Cowan S, Fordyce C, Gin K, Lau B, Virani S, Wood D, Krahn A, Fournier A, Gupta A, Hardiman S, Jackson S, Sapp J, Lamarche Y, Mansour S, Marelli A, Roifman I, Ruel M, Small G, Turgeon R, Zieroth S.

Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement

Holm AM, Mehra MR, Courtwright A, Teuteberg J, Sweet S, Potena L, Singer LG, Farrero M, Shullo MA, Benza R, Ensminger S, Aslam S.

Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID-19

Walsh MN, Ravichandran AK, Seasor E, Salerno CT.

A nationwide survey of UK cardiac surgeons' view on clinical decision making during the coronavirus disease 2019 (COVID-19) pandemic

Benedetto U, Goodwin A, Kendall S, Uppal R, Akowuah E.

COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?

Loffredo L, Violi F.

Quantifying additional COVID-19 symptoms will save lives

Menni C, Sudre CH, Steves CJ, Ourselin S, Spector TD.

A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption

Khodir AE, Samra YA, Said E.

Cardiovascular complications in COVID-19: A systematic review and meta-analysis

Kunutsor SK, Laukkanen JA.

The Next Wave of Health Care Strain Related to COVID-19: Heart Failure Patients Coming Back in Force: We Must Not Fail Them

Moayedi Y, Alba AC, Lee DS, Wijeysundera HC, Ross HJ.

COVID-19 and heart injury: Appropriate methodology is crucial for assessing the emerging evidence

Kollias A, Kyriakoulis KG, Stergiou GS.

COVID-19 pneumonia in a dual heart-kidney recipient

Stachel MW, Gidea CG, Reyentovich A, Mehta SA, Moazami N.

Utilization and Appropriateness of Transthoracic Echocardiography in Response to the COVID-19 Pandemic

Ward RP, Lee L, Ward TJ, Lang RM.

Echocardiography in Pandemic: Front-Line Perspective, Expanding Role of Ultrasound, and Ethics of Resource Allocation

Drake DH, De Bonis M, Covella M, Agricola E, Zangrillo A, Zimmerman KG, Cobey FC.

Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography

Zhang L, Wang B, Zhou J, Kirkpatrick J, Xie M, Johri AM.

Echocardiography in the Time of COVID-19

Picard MH, Weiner RB.

Specific Considerations for the Protection of Patients and Echocardiography Service Providers When Performing Perioperative or Periprocedural Transesophageal Echocardiography during the 2019 Novel Coronavirus Outbreak: Council on Perioperative Echocardiography Supplement to the Statement of the

Nicoara A, Maldonado Y, Kort S, Swaminathan M, Mackensen GB.

Specific Considerations for Sonographers When Performing Echocardiography during the 2019 Novel Coronavirus Outbreak: Supplement to the American Society of Echocardiography Statement

Mitchell C, Collins K, Hua L, McClanahan C, Shea E, Umland M, Wasserman M.

ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology

Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M.

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA investigators.

Impact of COVID-19 on Peripheral Arterial Disease Treatment

Li W, Chen X, Feng H.

Potential role of statins in COVID-19

Lee KCH, Sewa DW, Phua GC.

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence

Turgeon RD, Zieroth S, Bewick D, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lau B, Leong-Poi H, Mansour S, Marelli A, Quraishi AR, Roifman I, Ruel M, Sapp J, Singh G, Small G, Virani S, Wood DA, Krahn A.

Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak Insights from the German-wide Helios hospital network

Bollmann A, Hohenstein S, Meier-Hellmann A, Kuhlen R, Hindricks G; Helios hospitals, Germany.

COVID-19-Associated Myocarditis in an Adolescent

Trogen B, Gonzalez FJ, Shust GF.

Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients

Calò LA, Davis PA, Rigato M, Sgarabotto L.

Are COVID-19 patients with hypertension at higher risk in China?

Wang S, Chen Y, Wang L, Liu H, Han P.

Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19

Mazzanti A, Briani M, Kukavica D, Bulian F, Marelli S, Trancuccio A, Monteforte N, Manciulli T, Morini M, Carlucci A, Viggiani G, Cannata F, Negri S, Bloise R, Memmi M, Gambelli P, Carbone A, Molteni M, Bianchini R, Salgarello R, Sozzi S, De Cata P, Fanfulla F, Ceriana P, Locatelli C, Napolitano C, Chiovato L, Tomasi L, Stefanini G, Condorelli G, Priori SG.

Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2?

Cao X, Yin R, Albrecht H, Fan D, Tan W.

Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality

Cannata F, Chiarito M, Reimers B, Azzolini E, Ferrante G, My I, Viggiani G, Panico C, Regazzoli D, Ciccarelli M, Voza A, Aghemo A, Li H, Wang Y, Condorelli G, Stefanini GG.

Antihypertensive drugs in COVID-19 infection

Pinto-Sietsma SJ, Flossdorf M, Buchholz VR, Offerhaus J, Bleijendaal H, Beudel M, Volders PGA, Ter Bekke RMA, Dormans T, Zwetsloot PP, de Jager P, Massberg S, Rämer P, Wendtner C, Hoffmann E, Rothe K, Feihl S, Kessler T, Pinto YM, Schunkert H.

COVID-19 and the healthcare workers

Kalra A, Michos ED, Chinnaiyan KM.

Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations

Snyder EM, Johnson BD.

Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis

Demirbaş A, Elmas ÖF, Türsen Ü, Atasoy M, Lotti T.

Author Correction: COVID-19: the vasculature unleashed

Teuwen LA, Geldhof V, Pasut A, Carmeliet P.

Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI

COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?

Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM.

Coronavirus disease 2019 (COVID-19) and ischemic colitis: An under-recognized complication

Chan KH, Lim SL, Damati A, Maruboyina SP, Bondili L, Abu Hanoud A, Slim J.

Is it Possible to Safely Maintain a Regular Vascular Practice During the COVID-19 Pandemic?

Pini R, Faggioli G, Vacirca A, Gallitto E, Mascoli C, Attard L, Viale P, Gargiulo M.

COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality

Sánchez-Recalde Á, Solano-López J, Miguelena-Hycka J, Martín-Pinacho JJ, Sanmartín M, Zamorano JL.

Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes

Lauck S, Forman J, Borregaard B, Sathananthan J, Achtem L, McCalmont G, Muir D, Hawkey MC, Smith A, H√∏jberg Kirk B, Wood DA, Webb JG.

Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties

Schiavone M, Gobbi C, Biondi-Zoccai G, D'Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, Mancone M, Forleo GB.

Intramural Hematoma as Unexpected Complication of COVID-19 Infection

Terzi F, Cefarelli M, Fattori R, Di Eusanio M.

Acute coronary syndrome in the time of the COVID-19 pandemic

Ashraf S, Ilyas S, Alraies MC.

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, Lindenfeld J, McMurray JJV, Mehra M, Metra M, Packer M, Pieske B, Pocock SJ, Ponikowski P, Rosano GMC, Teerlink JR, Tsutsui H, Van Veldhuisen DJ, Verma S, Voors AA, Wittes J, Zannad F, Zhang J, Seferovic P, Coats AJS.

When a delayed cardiology consultation leads to a massive left ventricle pseudoaneurysm: collateral effects of the COVID-19 pandemic

Rimac G, Marzouk M, Dumont É, Paradis JM.

Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs

Ruilope LM, Tamargo J, Ruiz-Hurtado G.

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, Zhao Y, Wang H, Liu Y, Yin Z, Zhang R, Wang R, Yang M, Hui C, Wijns W, McEvoy JW, Soliman O, Onuma Y, Serruys PW, Tao L, Li F.

Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center

Abdelaziz HK, Abdelrahman A, Nabi A, Debski M, Mentias A, Choudhury T, Patel B, Saad M.

A current review of COVID-19 for the cardiovascular specialist

Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA.

Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy

Franco F, Alessandro Z, Carlo C, Domenico M, Giampaolo P, Loris R, Salvatore S, Sakis T, Giovanni T, Roberto V, Martina PM, Dario G, Sabino I.

Anticipating and curtailing the cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19

Oren O, Gersh BJ, Blumenthal RS.

The role of vascular surgeons in the treatment of COVID-19-associated pulmonary embolism

Patelis N, Bisdas T, Tsiachris D, Stefanadis CI.

Accidental vertebral artery injury in a COVID-19 patient

Baccellieri D, Bilman V, Ardita V, Loschi D, Melissano G, Chiesa R.

Strategy for treating vascular emergencies during the COVID-19 pandemic in China

Wang J, Kuang M, Chen L, Lian C, Zhao L, Wang S.

Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak"

Ruggiero G, Arcangeli F, Lotti T, Ametrano O, Ruggiero C, Cucchiara S, Oliva S.

COVID-19 Disruption in Cardiothoracic Surgical Training: An Opportunity to Enhance Education

Fuller S, Vaporciyan A, Dearani JA, Stulak JM, Romano JC.

Acute myocardial injury: a novel clinical pattern in children with COVID-19

Wolfler A, Mannarino S, Giacomet V, Camporesi A, Zuccotti G.

Acute complicated type B aortic dissection during the New York City COVID-19 surge

Ikeda S, Shih M, Rhee RY, Youdelman BA.

Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"

Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA.

Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"

Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Wang Y, Yuan Y, Rohit L, Liu PP, Li H.

COVID-19: Crisis Management in Congenital Heart Surgery

Stephens EH, Dearani JA, Guleserian KJ, Overman DM, Tweddell JS, Backer CL, Romano JC, Bacha E.

Prevalence of COVID-19 in Out-of-Hospital Cardiac Arrest: Implications for Bystander CPR

Sayre MR, Barnard LM, Counts CR, Drucker CJ, Kudenchuk PJ, Rea TD, Eisenberg MS.

Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, Reiger M, Neumann AU, Lunjani N, Traidl-Hoffmann C, Nadeau K, O'Mahony L, Akdis CA, Sokolowska M.

Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic

Chen KN, Gao S, Liu L, He J, Jiang GN, He J.

Letter: Thrombotic Neurovascular Disease in COVID-19 Patients

Sweid A, Hammoud B, Weinberg JH, Oneissi M, Raz E, Shapiro M, DePrince M, Tjoumakaris S, Gooch MR, Herial NA, Zarzour H, Romo V, Rosenwasser RH, Jabbour P.

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?

Shyh GI, Nawarskas JJ, Cheng-Lai A.

[Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19]

Zhang D, Lyu JT, Zhang B, Zhang XM, Lin ZJ.

31 days of COVID-19-cardiac events during restriction of public life-a comparative study

Rattka M, Baumhardt M, Dreyhaupt J, Rothenbacher D, Thiessen K, Markovic S, Rottbauer W, Imhof A.

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Kabra R, Natale A, Poe S, Saha SA, Russo AM.

Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction

Yolcu M, Gunesdogdu F, Bektas M, Bayirli DT, Serefhanoglu K.

Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink

Sattar Y, Connerney M, Ullah W, Rauf H, Mamtani S, Luddington S, Alraies MC.

Cardiopulmonary resuscitation in COVID-19 patients

Chahar P, Marciniak D.

Covid-19: Pandemic is having "severe" impact on non-communicable disease care, WHO survey finds

Dyer O.

POCUS to Guide Fluid Therapy in COVID-19

Thalappillil R, Tam CW.

Considerations for Heart Failure Care During the Coronavirus Disease 2019 (COVID-19) Pandemic

DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M.

COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity

Eiras S, Álvarez E, Brión M, González-Juanatey JR.

Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality

Zhou F, Liu YM, Xie J, Li H, Lei F, Yang H, Qin JJ, Cai J, Zhang XJ, Wu B, Xia M, Xiang D, Yang C, Ma XL, Xu Q, Lu Z, Lu H, Xia X, Wang D, Liao X, Peng G, Yang J, Huang X, Zhang BH, Yuan Y, Wei X, Liu PP, Wang Y, Zhang P, She ZG, Xia J, Li H.

[Cardiac biomarkers and COVID-19 - Phenotypes and Interpretation]

Salbach C, Giannitsis E.

Letter to the Editor: Extracorporeal cardiopulmonary resuscitation should not be performed on confirmed or suspected COVID-19 patients

Kandori K, Narumiya H, Iizuka R.

Right-to-left interatrial shunt in COVID-19 patients with pulmonary embolism

Fabre O, Rebet O, Hysi I.

Covid-19 may be exacerbated by right-to-left interatrial shunt

Rajendram R, Kharal GA, Puri R.

Two hits to the renin-angiotensin system may play a key role in severe COVID-19

Tseng YH, Yang RC, Lu TS.

Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea

Carnevale S, Beretta P, Morbini P.

Cardiovascular Implications in Patients Infected with Covid-19 and the Importance of Social Isolation to Reduce Dissemination of the Disease

Costa JA, Silveira JA, Santos SCMD, Nogueira PP.

The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases

Askin L, Tanrıverdi O, Askin HS.

COVID-19, Vascular Diseases, and Vascular Services

Puech-Leão P, César LAM, De Luccia N.

The role of Angiology and Vascular Surgery in the COVID-19 pandemic

Barros BCS, Maia AB, Marques MA, Prette-Junior PR, Fiorelli SKA, Cerqueira FC.

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

Roffi M, Capodanno D, Windecker S, Baumbach A, Dudek D.

Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction

Yolcu M, Gunesdogdu F, Bektas M, Bayirli DT, Serefhanoglu K.

Letter to the Editor regarding "Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?"

Fernandes TM, Papamatheakis DG, Poch DS, Kim NH.

Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome

Nakajima K.

Acro-ischemia and COVID-19 infection: clinical and histopathological features

Calv√£o J, Relvas M, Pinho A, Brinca A, Cardoso JC.

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, Leruez-Ville M, Quartier P, Léger PL, Geslain G, Semaan N, Moulin F, Bendavid M, Jean S, Poncelet G, Renolleau S, Oualha M.

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin

Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli M, Park DS, Chinitz LA, Jankelson L.

COVID-19 and myocardial injury: is there a role for interleukin-1 inhibition?

Imazio M, Andreis A, De Ferrari GM.

Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement

Arnold RH, Tideman PA, Devlin GP, Carroll GE, Elder A, Lowe H, Macdonald PS, Bannon PG, Juergens C, McGuire M, Mariani JA, Coffey S, Faddy S, Brown A, Inglis S, Wang WYS.

The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic

Osman I, Cotzia P, Moran U, Donnelly D, Arguelles-Grande C, Mendoza S, Moreira A.

Editor's presentation: Staying healthy and fighting cardiovascular disease at the time of COVID

Piepoli MF.

Delivering healthcare at distance to cardiac patients during the COVID-19 pandemic: Experiences from clinical practice

Klompstra L, Jaarsma T.

Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Koufakis T, Metallidis S, Zebekakis P, Ajjan RA, Kotsa K.

Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin

Maraj I, Hummel JP, Taoutel R, Chamoun R, Workman V, Li C, Tran L, DelVecchio A, Howes C, Akar JG.

Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis

Aikawa T, Takagi H, Ishikawa K, Kuno T.

Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA

Franks CE, Scott MG, Farnsworth CW.

Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621

Rubin EJ.

Impact of COVID-19 on the vascular interventionist

Mousa AY, Broce M.

Managing Severe Aortic Stenosis in the COVID-19 Era

Tanguturi VK, Lindman BR, Pibarot P, Passeri JJ, Kapadia S, Mack MJ, Inglessis I, Langer NB, Sundt TM, Hung J, Elmariah S.

COVID-19 associated central nervous system vasculopathy

Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN.

COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study

Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, Liu W, Tu C, Zhu M, Xiong B.

Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study

Andersson C, Gerds T, Fosb√∏l E, Phelps M, Andersen J, Lamberts M, Holt A, Butt JH, Madelaire C, Gislason G, Torp-Pedersen C, K√∏ber L, Schou M.

An educational case series of electrocardiographs during the COVID-19 pandemic and their implications on therapy

Sia CH, Ngiam JN, Chew N, Beh DLL, Poh KK.

Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?

Bobkova I, Kamyshova E, Rudenko T, Stavrovskaya E, Moiseev S.

Type 3 hypersensitivity in COVID-19 vasculitis

Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, Nasillo V, Manenti A, Maiorana A.

Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19

Uzelac I, Iravanian S, Ashikaga H, Bhatia NK, Herndon C, Kaboudian A, Gumbart JC, Cherry EM, Fenton FH.

High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients

Voicu S, Bonnin P, Stépanian A, Chousterman BG, Le Gall A, Malissin I, Deye N, Siguret V, Mebazaa A, Mégarbane B.

Related molecular mechanisms of COVID-19, hypertension, and diabetes

Akkus E, Sahin M.

Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter

Hammad TA, Parikh M, Tashtish N, Lowry CM, Gorbey D, Forouzandeh F, Filby SJ, Wolf WM, Costa MA, Simon DI, Shishehbor MH.

Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge

Lopez JJ, Ebinger JE, Allen S, Yildiz M, Henry TD.

The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic

Bromage DI, Cannata A, Rind IA, Gregorio C, Piper S, Shah AM, McDonagh TA.

The great pandemic of 2020: A defining moment for Heart Rhythm Societies and their members

Lemery R.

Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia"

Salehi S, Gholamrezanezhad A.

Charting a Safe and Expeditious Course Back to Elective Cardiac Surgery During the COVID-19 Pandemic

Frankel WC, Nguyen TC, Weiss AJ.

Can an Old Ally Defeat a New Enemy?

Gurbel PA, Bliden KP, Schrör K.

Validating QT-Interval Measurement Using the Apple Watch ECG to Enable Remote Monitoring During the COVID-19 Pandemic

Strik M, Caillol T, Ramirez FD, Abu-Alrub S, Marchand H, Welte N, Ritter P, Haïssaguerre M, Ploux S, Bordachar P.

Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology

Eid-Lidt G, Farjat Pasos JI.

Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk

Mattioli AV, Ballerini Puviani M.

Strategic Deployment of Cardiology Fellows-in-Training Using the Accreditation Council for Graduate Medical Education COVID-19 Framework

Gallagher MJ, Bloomingdale R, Berman AD, Williamson BD, Dixon SR, Safian RD.

COVID-19: ACE2centric infective disease?

Verdecchia P, Cavallini C, Spanevello A, Angeli F.

Capacity changes in German certified chest pain units during COVID-19 outbreak response

Settelmeier S, Rassaf T, Giannitsis E, Münzel T, Breuckmann F.

Acute Mesenteric Ischemia in Severe Coronavirus-19 (COVID-19): Possible Mechanisms and Diagnostic Pathway

Parry AH, Wani AH, Yaseen M.

COVID-19 and Cardiac Implantable Electronic Device Remote Monitoring: Crocodile Tears or New Opportunity?

Russo V, Nigro G, D'Onofrio A.

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management

Ceriello A, Schnell O.

Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC)

Bhatia RT, Marwaha S, Malhotra A, Iqbal Z, Hughes C, Börjesson M, Niebauer J, Pelliccia A, Schmied C, Serratosa L, Papadakis M, Sharma S.

Cardiovascular conditions and COVID-19

Rahman A.

Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review

Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA.

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia

Fan BE, Chia YW, Sum CLL, Kuperan P, Chan SSW, Ling LM, Tan GWL, Goh SSN, Wong LH, Lim SP, Lim KGE, Tan HT, Ang MK, Lau SL, Ong KH, Ng J.

Statement from the North American Society for Cardiovascular Imaging on imaging strategies to reduce the scarcity of healthcare resources during the COVID-19 outbreak

Kicska G, Litmanovich DE, Ordovas KG, Young PM, Dennie C, Truong QA, Abbara S, Kirsch J.

Tetralogy of Fallot palliation in a COVID-19 positive neonate

Salik I, Mehta B.

COVID-19-RELATED AORTIC THROMBOSIS: A REPORT OF FOUR CASES

Gomez-Arbelaez D, Ibarra-Sanchez G, Garcia-Gutierrez A, Comanges-Yeboles A, Ansuategui-Vicente M, Gonzalez-Fajardo JA.

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Ganatra S, Dani SS, Shah S, Asnani A, Neilan TG, Lenihan D, Ky B, Barac A, Hayek SS, Leja M, Herrmann J, Thavendiranathan P, Fradley M, Bang V, Shreyder K, Parikh R, Patel R, Singh A, Brar S, Guha A, Gupta D, Mascari P, Patten R, Venesy D, Nohria A, Resnic FS.

Echocardiographic Findings in Covid-19 Pneumonia

Mahmoud-Elsayed HM, Moody WE, Bradlow WM, Khan-Kheil AM, Hudsmith LE, Steeds RP.

Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis

Pirola CJ, Sookoian S.

COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome

Hu J, Zhang X, Zhang X, Zhao H, Lian J, Hao S, Jia H, Yang M, Lu Y, Xiang D, Cai H, Zhang S, Gu J, Ye C, Yu G, Jin C, Zheng L, Yang Y, Sheng J.

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend

Peng HC, Hussin N, Nalliah S, Ooi WT, Tang XY, Zachariah S, Singh GPSJ, Rani RA, Perumal K, Kooi CW.

Response to the letter, "The cardiovascular burden of congenital heart disease - not only in times of COVID-19"

Tan W, Aboulhosn J.

Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research

Frigerio M.

Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic

Chitturi KR, Faza NN, Little SH, Kleiman NS, Reardon MJ, Goel SS.

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Singh AK, Gupta R, Misra A.

Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Mahajan K, Gaur N.

Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement from the Cardiac Society of Australia and New Zealand (CSANZ)

Nicholls SJ, Nelson M, Astley C, Briffa T, Brown A, Clark R, Colquhoun D, Gallagher R, Hare DL, Inglis S, Jelinek M, O'Neil A, Tirimacco R, Vale M, Redfern J.

Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia

Roncati L, Manenti A, Manco G, Farinetti A.

Inferior vena cava filter in a patient with COVID-19 pneumonia to prevent a massive pulmonary embolism

Cena T, Bazzano S, Berni P, Vignazia GL, Grossi F, Stanca C, Cammarota G, Della Corte F, Vaschetto R.

Surveillance for COVID-19 in cardiac inpatients: containing COVID-19 in a specialised cardiac centre

Wee LE, Wen R, Jean Sim XY, Ng K, Phoon PC, Conceicao EP, Aung MK, Lung Wong AS, Chua TSJ, Venkatachalam I.

Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot

Varikasuvu SR, Dutt N.

Increased cardiovascular mortality in African Americans with COVID-19

McGonagle D, Plein S, O'Donnell JS, Sharif K, Bridgewood C.

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS.

Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study

Marijon E, Karam N, Jost D, Perrot D, Frattini B, Derkenne C, Sharifzadehgan A, Waldmann V, Beganton F, Narayanan K, Lafont A, Bougouin W, Jouven X.

COVID-19: long-term effects on the community response to cardiac arrest?

Perkins GD, Couper K.

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction

Seif S, Ayuna A, Kumar A, Macdonald J.

ST-elevation myocardial infarction in the COVID-19 era

Versaci F, Scappaticci M, Calcagno S, Del Prete A, Romeo F, Peruzzi M, Cavarretta E, Frati G.

2019 novel coronavirus: what is currently known, cardiovascular implications and management

Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, Di Giusto F, Crea F.

COVID-19 pandemic and cardiovascular disease: where do we stand?

Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP.

First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report

Bemtgen X, Krüger K, Supady A, Duerschmied D, Schibilsky D, Bamberg F, Bode C, Wengenmayer T, Staudacher DL.

Food protein-derived antihypertensive peptides in the COVID-19 pandemic: friends of foes?

Goudarzi M, Garavand F, Madadlou A, Fogliano V.

Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction

Giardini V, Carrer A, Casati M, Contro E, Vergani P, Gambacorti-Passerini C.

"COVID-Mask": an atypical livedoid manifestation of COVID-19 observed in a northern Italy hospital

Conforti C, Zalaudek I, Giuffrida R, Zorat F, Grillo A, Colapietro N, Francica M, di Meo N.

COVID-19 and Congenital Heart Disease: Perspectives from a Resource-limited Setting

Sachdeva S, Saxena A.

Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure"

Fedson DS, Opal SM, Rordam OM.

Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic

Yerasi C, Case BC, Forrestal BJ, Chezar-Azerrad C, Hashim H, Ben-Dor I, Satler LF, Mintz GS, Waksman R.

Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand

Lo STH, Yong AS, Sinhal A, Shetty S, McCann A, Clark D, Galligan L, El-Jack S, Sader M, Tan R, Hallani H, Barlis P, Sechi R, Dictado E, Walton A, Starmer G, Bhagwandeen R, Leung DY, Juergens CP, Bhindi R, Muller DWM, Rajaratnum R, French JK, Kritharides L; Interventional council of CSANZ and COVID-19 Interventional cardiology working group.

Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients

Faggiano P, Bonelli A, Paris S, Milesi G, Bisegna S, Bernardi N, Curnis A, Agricola E, Maroldi R.

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19

Dabaghian F, Khanavi M, Zarshenas MM.

COVID-19 pandemic-Some cardiovascular considerations from the trench

Cortese B.

COVID-19 treatments, QT interval and arrhythmic risk: the need for an international Registry on Arrhythmias

Crotti L, Arbelo E.

Declines in Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience

Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, Januzzi JL, Butler J, Adler DS, Solomon SD, Vaduganathan M.

Ramipril in High Risk Patients with COVID-19

Amat-Santos IJ, Santos-Martinez S, López-Otero D, Nombela-Franco L, Gutiérrez-Ibanes E, Del Valle R, Muñoz-García E, Jiménez-Diaz VA, Regueiro A, González-Ferreiro R, Benito T, Sanmartin-Pena XC, Catalá P, Rodríguez-Gabella T, Delgado-Arana JR, Carrasco-Moraleja M, Ibañez B, San Román JA.

The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials

Bagiella E, Bhatt DL, Gaudino M.

Declining Admissions for Acute Cardiovascular Illness: The Covid-19 Paradox

Ebinger JE, Shah PK.

All those D-dimers in COVID-19

Thachil J.

Management of heart transplant candidates in the time of COVID-19 pandemic: looking for answers

Pascale R, Trapani F, Potena L, Martin-Suarez S, Viale P, Giannella M.

Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic

Rothstein ES, Welch TD, Andrus BW, Jayne JE.

SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism

Mori J, Oudit GY, Lopaschuk GD.

The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study

Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, Gal Oz A, Rothschild E, Baruch G, Peri Y, Arbel Y, Topilsky Y.

The decline of coronary angiography and percutaneous coronary intervention procedures in patients with acute myocardial infarction in Poland during the COVID-19 pandemic

Legutko J, Niewiara Ł, Bartuś S, Dobrzycki S, Gąsior M, Gierlotka M, Kochman J, Lesiak M, Matysek J, Ochała A, Pawłowski T, Gil R, Witkowski A.

Early results from telephone follow-up of patients with cardiovascular implantable electronic devices during the coronavirus pandemic

Paskudzka D, Kołodzińska A, Cacko A, Stolarz P, Łyżwiński Ł, Opolski G, Grabowski M.

Deceases in Acute Heart Failure Hospitalizations during COVID-19

Cox ZL, Lai P, Lindenfeld J.

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic. A survey by the European Society of Cardiology

Pessoa-Amorim G, Camm CF, Gajendragadkar P, De Maria GL, Arsac C, Laroche C, Zamorano JL, Weidinger F, Achenbach S, Maggioni AP, Gale CP, Poppas A, Casadei B.

Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019

Prabhu V, Hsu E, Lestin S, Soltanianzadeh Y, Hadi S.

Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19

Centurión OA, Scavenius KE, García LB, Torales JM, Miño LM.

Effects of the COVID-19 Pandemic on the Management of Patients With ST-Elevation Myocardial Infarction in a Tertiary Cardiovascular Center

Firouzi A, Baay M, Mazayanimonfared A, Pouraliakbar H, Sadeghipour P, Noohi F, Maleki M, Peighambari MM, Kiavar M, Abdi S, Maadani M, Shakerian F, Zahedmehr A, Kiani R, Ansari MJA, Rashidinejad A, Hosseini Z.

Delayed presentation of acute ischemic strokes during the COVID-19 crisis

Schirmer CM, Ringer AJ, Arthur AS, Binning MJ, Fox WC, James RF, Levitt MR, Tawk RG, Veznedaroglu E, Walker M, Spiotta AM; Endovascular Research Group (ENRG).

CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic

Wahi S, Thomas L, Stanton T, Taylor A, Mahadevan D, Evans G, Playford D, To A, Davis M, Anderson B, Buckley B.

Triage criteria for cardiopulmonary resuscitation and advanced life support during the COVID-19 epidemic

Real de Asúa D, Galván JM, Iglesias J, Fernández J; en representación del Grupo de Trabajo sobre triaje durante la epidemia de COVID-19 del Hospital Universitario de La Princesa; Grupo de trabajo sobre triaje durante la epidemia de COVID-19 del Hospital Universitario de La Princesa.

Heart Failure Editorial Emergencies in the COVID-19 Era

O'Connor CM.

Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris

Escalard S, Maïer B, Redjem H, Delvoye F, Hébert S, Smajda S, Ciccio G, Desilles JP, Mazighi M, Blanc R, Piotin M.

Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China

Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, Yu H, Tian DS, Wang W.

Out of Hospital Management of LVAD Patients During COVID-19 Outbreak

Mariania S, Schmittoa JD.

Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?

Kim IC, Han S.

Myocardial injury in severe COVID-19 infection

Jaffe AS, Cleland JGF, Katus HA.

Does epicardial fat contribute to COVID-19 myocardial inflammation?

Malavazos AE, Goldberger JJ, Iacobellis G.

The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system

Offringa A, Montijn R, Singh S, Paul M, Pinto YM, Pinto-Sietsma SJ.

Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment

De Lazzari C, De Lazzari B, Iacovoni A, Marconi S, Papa S, Capoccia M, Badagliacca R, Vizza CD.

Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19

Ponti G, Ruini C, Tomasi A.

Family Engagement in the Cardiovascular Intensive Care Unit in the COVID Era

Goldfarb M, Bibas L, Burns K.

Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology

Zhang Y, Stewart Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M.

Heart failure management during COVID-19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre

Salzano A, D'Assante R, Stagnaro FM, Valente V, Crisci G, Giardino F, Arcopinto M, Bossone E, Marra AM, Cittadini A.

Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring

Ramireddy A, Chugh H, Reinier K, Ebinger J, Park E, Thompson M, Cingolani E, Cheng S, Marban E, Albert CM, Chugh SS.

Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern?

Kamp TJ, Hamdan MH, January CT.

Decreased myocardial infarction admissions during COVID times: what can we learn?

Niccoli G, Luescher TF, Crea F.

The COVID-19 Pandemic: A Challenge for the Cardiovascular Health

Crisafulli A, Pagliaro P.

COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy

Galastri FL, Valle LGM, Affonso BB, Silva MJ, Garcia RG, Junior MR, Ferraz LJR, de Matos GFJ, de la Cruz Scarin FC, Nasser F.

Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: "a position statement of the Egyptian Society of Cardiology"

Shaheen S, Awwad O, Shokry K, Abdel-Hamid M, El-Etriby A, Hasan-Ali H, Shawky I, Magdy A, Nasr G, Kabil H, Elhadidy A, Zaki M, Hegab A.

Using Telehealth Cardiopulmonary Rehabilitation during the COVID-19 Pandemic

Bryant MS, Fedson SE, Sharafkhaneh A.

The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population

Asokan I, Rabadia SV, Yang EH.

Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation

Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM.

Myocarditis detected after COVID-19 recovery

Sardari A, Tabarsi P, Borhany H, Mohiaddin R, Houshmand G.

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis

Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, Guan X, Gary T, Zhu Z.

Getting to the heart of the matter of COVID-19

Newby DE, Rahimi K.

COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?

Tadic M, Cuspidi C, Mancia G, Dell'Oro R, Grassi G.

C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism

Delanghe JR, De Buyzere ML, Speeckaert MM.

Cardiology practice in the COVID-19 era

Monsuez JJ.

The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes

Habibzadeh P, Moghadami M, Lankarani KB.

D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?

Breakey N, Escher R.

Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight

Marona M, Celinska-Spodar M, Spiewak M, Konopka A.

COVID-19 and Renin-Angiotensin system inhibition - role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Aleksova A, Ferro F, Gagno G, Cappelletto C, Santon D, Rossi M, Ippolito G, Zumla A, Beltrami AP, Sinagra G.

Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19

Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, Levi M, Samama CM, Thachil J, Giannis D, Douketis JD; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis, Haemostasis+.

Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis

Guo X, Zhu Y, Hong Y.

On barring the vascular gateway against severe COVID-19 disease

Perdrizet G, Hightower LE.

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing

Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S.

Rhythm blues in the time of coronavirus disease 2019 (COVID-19): how the cardiac electrophysiologist adapts to a viral pandemic in Singapore

Chia PL, Tan K, Tan LW, Chin PS, Foo D.

Hemodynamic Monitoring Options in COVID-19

Rozental O, Thalappillil R, White RS, Kumar SR, Tam CW.

COVID-19 Outbreak in France: Setup and Activities of a Mobile Extracorporeal Membrane Oxygenation Team During the First 3 Weeks

Haye G, Fourdrain A, Abou-Arab O, Berna P, Mahjoub Y.

Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19

Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z, Tian C, Du K, Zhu R, Wang L, Zhao L, Fan H, Luo S, Hu D.

Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia

Hu L, Gong L, Jiang Z, Wang Q, Zou Y, Zhu L.

Two consecutive myocardial tissue insults for inpatients with COVID-19

Su M, Peng J, Wu M, Deng W, Yang Y, Peng YG.

Impact of COVID-19 pandemic on HTA

STEMI during the COVID-19 Pandemic - An Evaluation of Incidence

Zitelny E, Newman N, Zhao D.

Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19

Dabaghian F, Khanavi M, Zarshenas MM.

COVID-19 pandemic and Vascular Surgery Unit

Yasri S, Wiwanitkit V.

Early Vascular Surgery Response to the COVID-19 Pandemic: Results of a Nationwide Survey

Latz CA, Boitano LT, Png CYM, Tanious A, Kibrik P, Conrad M, Eagleton M, Dua A.

Experience from a Singapore tertiary hospital with restructuring a vascular surgery practice in response to national and institutional policies during the COVID-19 pandemic

Ng JJ, Gan TRX, Niam JY, Menon RK, Ho P, Dharmaraj RB, Wong JCL, Choong AMTL.

MICROVASCULAR THROMBOSIS: EXPERIMENTAL AND CLINICAL IMPLICATIONS

Bray MA, Sartain SA, Gollamudi J, Rumbaut RE.

Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19)

Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blascoª P, Suarez-Valle A.

Mitigating the Psychological Harm of COVID-19 Pandemic for Clinicians

Kuehn BM.

Why the Use of Angiotensin II May Be a Fatal Mistake in Covid-19

Ferreira J, Mcmanus J, Jankowski CA, Searcy R.

Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications

Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G.